These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37943339)

  • 1. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
    Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4-Directed PET/CT with [
    Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W
    Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor-4 targeted PET/CT with
    Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
    Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
    J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4-directed PET/CT with [
    Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [
    Zhi Y; Werner RA; Schirbel A; Higuchi T; Buck AK; Kosmala A; Bley TA; Hagen R; Hackenberg S; Rosenwald A; Scherzad A; Gerhard-Hartmann E; Serfling SE
    Am J Nucl Med Mol Imaging; 2023; 13(5):208-216. PubMed ID: 38023816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging CXCR4 receptors expression for staging multiple myeloma by using
    Shekhawat AS; Singh B; Malhotra P; Watts A; Basher R; Kaur H; Hooda M; Radotra BD
    Br J Radiol; 2022 Aug; 95(1136):20211272. PubMed ID: 35731811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
    Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
    Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 PET imaging of mantle cell lymphoma using [
    Mayerhoefer ME; Raderer M; Lamm W; Pichler V; Pfaff S; Weber M; Kiesewetter B; Hacker M; Kazianka L; Staber PB; Wester HJ; Rohrbeck J; Simonitsch-Klupp I; Haug A
    Theranostics; 2021; 11(2):567-578. PubMed ID: 33391493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Lawal IO; Popoola GO; Mahapane J; Kaufmann J; Davis C; Ndlovu H; Maserumule LC; Mokoala KMG; Bouterfa H; Wester HJ; Zeevaart JR; Sathekge MM
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287237
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
    J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemokine Receptor-4 Targeted PET/CT Imaging with
    Hadebe B; Harry L; Gabela L; Masikane S; Patel M; Zwane S; Pillay V; Bipath P; Cebekhulu N; Nyakale N; Ramdass P; Msimang M; Aldous C; Sathekge M; Vorster M
    Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging.
    Kosmala A; Seifert S; Schneid S; Dreher N; Higuchi T; Weich A; Serfling SE; Hartrampf PE; Einsele H; Buck AK; Topp MS; Duell J; Werner RA
    Mol Imaging Biol; 2023 Aug; 25(4):758-764. PubMed ID: 37286923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [
    Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
    Mol Imaging Biol; 2024 Aug; 26(4):658-667. PubMed ID: 38627276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
    Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
    Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of [ 68 Ga]Ga-Pentixafor versus [ 18 F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study.
    Mirshahvalad SA; Manafi-Farid R; Fallahi B; Seifi S; Geramifar P; Emami-Ardekani A; Eftekhari M; Beiki D
    Nucl Med Commun; 2023 Sep; 44(9):803-809. PubMed ID: 37334548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using
    Buck AK; Haug A; Dreher N; Lambertini A; Higuchi T; Lapa C; Weich A; Pomper MG; Wester HJ; Zehndner A; Schirbel A; Samnick S; Hacker M; Pichler V; Hahner S; Fassnacht M; Einsele H; Serfling SE; Werner RA
    J Nucl Med; 2022 Nov; 63(11):1687-1692. PubMed ID: 35241482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
    Duell J; Krummenast F; Schirbel A; Klassen P; Samnick S; Rauert-Wunderlich H; Rasche L; Buck AK; Wester HJ; Rosenwald A; Einsele H; Topp MS; Lapa C; Kircher M
    J Nucl Med; 2021 Oct; 62(10):1415-1421. PubMed ID: 33579803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.